Epothilone Synthesis via Recombinant Fermentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a continuing need for more efficient methods to synthesize epothilones and their derivatives, which are promising anticancer agents, as existing methods are not cost-effective for commercial development.
Innovation Solution
The synthesis of epothilones is achieved through a combination of chemical synthetic and biosynthetic steps, including fermentation of recombinant cells expressing polyketide synthases, which reduces the cost of manufacture and facilitates their development as therapeutic agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If traditional chemical synthesis methods are used to prepare epothilones, then the synthesis can be achieved with established techniques, but the cost of manufacture is high and efficiency is low
Solution Approach 1:
The patent uses polyketide synthase enzymes as biological intermediaries to catalyze the formation of key intermediates ( compounds of formulae II and III) in the epothilone synthesis pathway. These enzymatic intermediaries enable more efficient and cost-effective production compared to traditional chemical synthesis methods, while maintaining the ability to produce the desired epothilone compounds.
2Ease of manufacture
If fermentation of recombinant cells is used to obtain intermediates, then the cost of manufacture is reduced, but the process complexity increases
Solution Approach 1:
The patent divides the overall epothilone synthesis process into distinct segments: (1) fermentation of recombinant cells to produce intermediate compounds of formulae II and III, and (2) chemical synthesis steps to complete the epothilone structure. This segmentation allows each stage to be optimized independently, reducing overall process complexity while maintaining cost benefits.
Solution Approach 2:
The patent introduces polyketide synthase-expressing recombinant cells as biological intermediaries that produce specific intermediate compounds (formulae II and III). These intermediates then serve as starting materials for subsequent chemical synthesis steps, creating a bridge between biological and chemical synthesis approaches and simplifying the overall process architecture.
3Productivity
If polyketide synthases are used in biosynthetic steps, then the synthesis efficiency and cost-effectiveness improve, but the technical complexity of the method increases
Solution Approach 1:
The patent employs polyketide synthase enzymes that can catalyze multiple steps in the biosynthetic pathway, producing different intermediates (compounds of formulae II and III) from the same enzyme system. This multi-functionality increases synthesis efficiency while avoiding the need for multiple different enzymatic systems, thereby limiting the increase in technical complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces the cost of producing epothilones, making them more viable for commercial development as therapeutic agents with potential for improved antitumor activity.
Implementation Method 1
methods for preparing compounds of formula (II) through the fermentation of host cells comprising polyketide synthases capable of converting compounds of the formula (I) into compounds of formula (II)
Data Source
AI summary
The invention provides novel compounds that may be used as intermediates in the preparation of epothilones, epothilone analogs and derivative, as well as new synthetic methods for producing the intermediates and products.